| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.74e-12 | 43 | 41 | 7 | GO:0030280 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPU HNRNPR HNRNPA3 | 7.75e-08 | 276 | 41 | 8 | GO:0003730 |
| GeneOntologyMolecularFunction | mRNA binding | HNRNPA0 DDX3Y TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.02e-06 | 694 | 41 | 10 | GO:0003729 |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 1.31e-06 | 11 | 41 | 3 | GO:0098505 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 2.27e-06 | 13 | 41 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 3.59e-06 | 15 | 41 | 3 | GO:0098847 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 7.61e-06 | 19 | 41 | 3 | GO:1990825 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 7.79e-06 | 134 | 41 | 5 | GO:0003697 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 7.83e-06 | 62 | 41 | 4 | GO:0061980 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 8.89e-06 | 64 | 41 | 4 | GO:0036002 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.23e-05 | 3 | 41 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 4.10e-05 | 5 | 41 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | regulatory region RNA binding | 4.10e-05 | 5 | 41 | 2 | GO:0001069 | |
| GeneOntologyMolecularFunction | structural molecule activity | 6.50e-05 | 891 | 41 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 7.53e-05 | 40 | 41 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 7.82e-05 | 111 | 41 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | miRNA binding | 1.30e-04 | 48 | 41 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.44e-04 | 130 | 41 | 4 | GO:0005200 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 2.24e-04 | 11 | 41 | 2 | GO:1990814 | |
| GeneOntologyMolecularFunction | annealing activity | 3.69e-04 | 14 | 41 | 2 | GO:0140666 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 2.90e-03 | 39 | 41 | 2 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 3.85e-03 | 45 | 41 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.11e-03 | 753 | 41 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.63e-03 | 562 | 41 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 7.88e-03 | 65 | 41 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 8.12e-03 | 66 | 41 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 8.12e-03 | 66 | 41 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 8.69e-03 | 1160 | 41 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.12e-02 | 78 | 41 | 2 | GO:0003724 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.12e-02 | 78 | 41 | 2 | GO:0003725 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.17e-02 | 80 | 41 | 2 | GO:0008186 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.26e-02 | 83 | 41 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.73e-02 | 98 | 41 | 2 | GO:0031491 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.16e-14 | 75 | 41 | 9 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.88e-13 | 99 | 41 | 9 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.16e-13 | 100 | 41 | 9 | GO:0045103 | |
| GeneOntologyBiologicalProcess | keratinization | 6.15e-12 | 87 | 41 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.02e-10 | 189 | 41 | 9 | GO:0030216 | |
| GeneOntologyBiologicalProcess | skin development | KRT6A KRT6B KRT9 KRT10 KRT6C KRTAP6-1 KRT74 KRT84 KRT77 KRTAP6-3 | 2.26e-09 | 373 | 41 | 10 | GO:0043588 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 3.73e-09 | 284 | 41 | 9 | GO:0009913 | |
| GeneOntologyBiologicalProcess | epidermis development | KRT6A KRT6B KRT9 KRT10 KRT6C KRTAP6-1 KRT74 KRT84 KRT77 KRTAP6-3 | 1.70e-08 | 461 | 41 | 10 | GO:0008544 |
| GeneOntologyBiologicalProcess | RNA splicing | TAF15 HNRNPA1L2 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.80e-08 | 502 | 41 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SOX17 KRT6A KRT6B KRT9 KRT10 KRT24 KRT6C KRTAP6-1 KRT74 KRT84 KRT77 KRTAP6-3 | 7.50e-08 | 870 | 41 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | mRNA processing | HNRNPA0 SRRT HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 9.08e-08 | 551 | 41 | 10 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.42e-07 | 358 | 41 | 8 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.42e-07 | 358 | 41 | 8 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.80e-07 | 362 | 41 | 8 | GO:0000375 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | HNRNPA0 SRRT TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.17e-06 | 917 | 41 | 11 | GO:0016071 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT6A KRT6B KRT9 KRT10 KRT24 OCLN KRT6C KRT74 LOXL1 KRT84 KRT77 | 1.78e-06 | 957 | 41 | 11 | GO:0097435 |
| GeneOntologyBiologicalProcess | epithelium development | SOX17 KRT6A KRT6B KRT9 KRT10 KRT24 ARID1A KRT6C KRTAP6-1 KRT74 KRT84 KRT77 KRTAP6-3 | 3.07e-06 | 1469 | 41 | 13 | GO:0060429 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 3.15e-06 | 115 | 41 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | RNA localization | 4.18e-06 | 217 | 41 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | mRNA transport | 9.79e-06 | 145 | 41 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.64e-05 | 77 | 41 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.81e-05 | 79 | 41 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | RNA processing | HNRNPA0 SRRT TAF15 HNRNPA1L2 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.27e-05 | 1500 | 41 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.40e-05 | 443 | 41 | 7 | GO:1903311 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.43e-05 | 175 | 41 | 5 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.43e-05 | 175 | 41 | 5 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.64e-05 | 178 | 41 | 5 | GO:0051236 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.65e-05 | 87 | 41 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 2.78e-05 | 88 | 41 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 3.84e-05 | 5 | 41 | 2 | GO:2000373 | |
| GeneOntologyBiologicalProcess | regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 3.84e-05 | 5 | 41 | 2 | GO:2000371 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.77e-05 | 101 | 41 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | positive regulation of isomerase activity | 8.04e-05 | 7 | 41 | 2 | GO:0010912 | |
| GeneOntologyBiologicalProcess | regulation of isomerase activity | 8.04e-05 | 7 | 41 | 2 | GO:0010911 | |
| GeneOntologyBiologicalProcess | G-quadruplex DNA unwinding | 8.04e-05 | 7 | 41 | 2 | GO:0044806 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | SOX17 HNRNPA0 TAF15 ARID1B HNRNPA1L2 FAM98B OCLN ARID1A HNRNPA1 HNRNPU DHX9 | 8.60e-05 | 1446 | 41 | 11 | GO:0010628 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.29e-04 | 249 | 41 | 5 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.76e-04 | 266 | 41 | 5 | GO:0033044 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 2.10e-04 | 11 | 41 | 2 | GO:0070934 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.51e-04 | 12 | 41 | 2 | GO:1900152 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.69e-04 | 158 | 41 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.71e-04 | 292 | 41 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | cellular response to potassium ion | 3.46e-04 | 14 | 41 | 2 | GO:0035865 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 3.47e-04 | 308 | 41 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 3.49e-04 | 69 | 41 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 3.52e-04 | 309 | 41 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 4.95e-04 | 333 | 41 | 5 | GO:0051054 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 5.14e-04 | 17 | 41 | 2 | GO:2000767 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 5.78e-04 | 18 | 41 | 2 | GO:0045760 | |
| GeneOntologyBiologicalProcess | primary miRNA processing | 7.16e-04 | 20 | 41 | 2 | GO:0031053 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 7.46e-04 | 207 | 41 | 4 | GO:0043484 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomere lengthening | 7.60e-04 | 90 | 41 | 3 | GO:0010833 | |
| GeneOntologyBiologicalProcess | response to potassium ion | 7.90e-04 | 21 | 41 | 2 | GO:0035864 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 8.11e-04 | 564 | 41 | 6 | GO:0051052 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 8.26e-04 | 373 | 41 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 9.16e-04 | 96 | 41 | 3 | GO:0006405 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 9.20e-04 | 219 | 41 | 4 | GO:0071248 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 1.12e-03 | 25 | 41 | 2 | GO:0032211 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.31e-03 | 27 | 41 | 2 | GO:1900151 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.39e-03 | 111 | 41 | 3 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance | 1.43e-03 | 112 | 41 | 3 | GO:0032204 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.51e-03 | 29 | 41 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.59e-03 | 432 | 41 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 1.96e-03 | 33 | 41 | 2 | GO:1904357 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.14e-03 | 129 | 41 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 2.17e-03 | 464 | 41 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | chromosome organization | 2.21e-03 | 686 | 41 | 6 | GO:0051276 | |
| GeneOntologyBiologicalProcess | response to arsenic-containing substance | 2.46e-03 | 37 | 41 | 2 | GO:0046685 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 2.46e-03 | 37 | 41 | 2 | GO:2000765 | |
| GeneOntologyBiologicalProcess | regulation of DNA biosynthetic process | 2.59e-03 | 138 | 41 | 3 | GO:2000278 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 2.65e-03 | 139 | 41 | 3 | GO:0051983 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance via telomere lengthening | 2.73e-03 | 39 | 41 | 2 | GO:1904358 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.87e-03 | 143 | 41 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 3.16e-03 | 42 | 41 | 2 | GO:0032205 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 3.16e-03 | 42 | 41 | 2 | GO:0070316 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 3.31e-03 | 43 | 41 | 2 | GO:2000279 | |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 3.46e-03 | 44 | 41 | 2 | GO:0060674 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 3.46e-03 | 44 | 41 | 2 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of ATP-dependent activity | 3.62e-03 | 45 | 41 | 2 | GO:0032781 | |
| GeneOntologyBiologicalProcess | miRNA processing | 4.10e-03 | 48 | 41 | 2 | GO:0035196 | |
| GeneOntologyCellularComponent | intermediate filament | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 1.78e-21 | 227 | 41 | 16 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 1.94e-20 | 263 | 41 | 16 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 HNRNPU | 2.91e-13 | 899 | 41 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 HNRNPU SRI | 1.72e-12 | 1179 | 41 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 HNRNPU SRI | 1.93e-12 | 1187 | 41 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | keratin filament | 1.35e-11 | 97 | 41 | 8 | GO:0045095 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 3.37e-08 | 97 | 41 | 6 | GO:0071013 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.84e-07 | 215 | 41 | 7 | GO:0005681 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.91e-05 | 287 | 41 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 5.60e-05 | 6 | 41 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | CRD-mediated mRNA stability complex | 5.60e-05 | 6 | 41 | 2 | GO:0070937 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | HNRNPA0 SRRT HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 7.85e-05 | 1194 | 41 | 10 | GO:1990904 |
| GeneOntologyCellularComponent | bBAF complex | 1.67e-04 | 10 | 41 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.74e-04 | 269 | 41 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | JUNB ARID1B HNRNPA1L2 ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU HNRNPR HNRNPA3 | 2.54e-04 | 1377 | 41 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 3.36e-04 | 14 | 41 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 3.36e-04 | 14 | 41 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 4.43e-04 | 16 | 41 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.58e-03 | 30 | 41 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | transcription regulator complex | 5.95e-03 | 596 | 41 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | 7.24e-03 | 1480 | 41 | 8 | GO:0000785 | |
| HumanPheno | Palmoplantar hyperkeratosis | 2.31e-06 | 129 | 17 | 6 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 2.53e-06 | 131 | 17 | 6 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 2.65e-06 | 132 | 17 | 6 | HP:0007556 | |
| HumanPheno | Abnormality of the plantar skin of foot | 1.19e-05 | 171 | 17 | 6 | HP:0100872 | |
| HumanPheno | Epidermal acanthosis | 2.42e-05 | 54 | 17 | 4 | HP:0025092 | |
| HumanPheno | Ubiquitin-positive cerebral inclusion bodies | 3.14e-05 | 3 | 17 | 2 | HP:0012083 | |
| HumanPheno | Steatocystoma multiplex | 6.27e-05 | 4 | 17 | 2 | HP:0012035 | |
| HumanPheno | Eruptive vellus hair cyst | 6.27e-05 | 4 | 17 | 2 | HP:0025248 | |
| HumanPheno | Abnormal fingernail morphology | 6.46e-05 | 230 | 17 | 6 | HP:0001231 | |
| HumanPheno | Hyperkeratosis | 6.95e-05 | 233 | 17 | 6 | HP:0000962 | |
| HumanPheno | Abnormality of keratinization | 9.00e-05 | 244 | 17 | 6 | HP:0001035 | |
| HumanPheno | White lesion of the oral mucosa | 9.61e-05 | 28 | 17 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 9.61e-05 | 28 | 17 | 3 | HP:0002745 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.04e-04 | 5 | 17 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.04e-04 | 5 | 17 | 2 | HP:0030268 | |
| HumanPheno | Abnormal palm morphology | 1.20e-04 | 521 | 17 | 8 | HP:0100871 | |
| HumanPheno | Abnormal skin morphology of the palm | 2.08e-04 | 413 | 17 | 7 | HP:0040211 | |
| HumanPheno | Abnormal epidermal morphology | 2.15e-04 | 94 | 17 | 4 | HP:0011124 | |
| HumanPheno | Onychogryposis of toenails | 2.18e-04 | 7 | 17 | 2 | HP:0008401 | |
| HumanPheno | Short distal phalanx of the 5th finger | 2.18e-04 | 7 | 17 | 2 | HP:0004227 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanx of the 5th finger | 2.18e-04 | 7 | 17 | 2 | HP:0009239 | |
| HumanPheno | Onychogryposis | 2.18e-04 | 7 | 17 | 2 | HP:0001819 | |
| HumanPheno | Onychogryposis of fingernail | 3.72e-04 | 9 | 17 | 2 | HP:0040036 | |
| HumanPheno | Palmoplantar keratoderma | 4.52e-04 | 114 | 17 | 4 | HP:0000982 | |
| HumanPheno | Calvarial hyperostosis | 4.64e-04 | 10 | 17 | 2 | HP:0004490 | |
| HumanPheno | Abnormal blistering of the skin | 4.67e-04 | 115 | 17 | 4 | HP:0008066 | |
| HumanPheno | Amyotrophic lateral sclerosis | 5.17e-04 | 49 | 17 | 3 | HP:0007354 | |
| HumanPheno | Palmoplantar blistering | 5.67e-04 | 11 | 17 | 2 | HP:0007446 | |
| HumanPheno | Frontotemporal dementia | 6.17e-04 | 52 | 17 | 3 | HP:0002145 | |
| HumanPheno | Angular cheilitis | 6.78e-04 | 12 | 17 | 2 | HP:0030318 | |
| HumanPheno | Hip pain | 6.78e-04 | 12 | 17 | 2 | HP:0030838 | |
| HumanPheno | Abnormal nail morphology | 8.26e-04 | 516 | 17 | 7 | HP:0001597 | |
| HumanPheno | Hypoplastic fifth fingernail | 9.32e-04 | 14 | 17 | 2 | HP:0008398 | |
| HumanPheno | Palmoplantar hyperhidrosis | 9.32e-04 | 14 | 17 | 2 | HP:0007410 | |
| HumanPheno | Epidermal thickening | 9.96e-04 | 379 | 17 | 6 | HP:0011368 | |
| HumanPheno | Ear pain | 1.07e-03 | 15 | 17 | 2 | HP:0030766 | |
| HumanPheno | Regional abnormality of skin | 1.10e-03 | 541 | 17 | 7 | HP:0011356 | |
| HumanPheno | Short 5th finger | 1.13e-03 | 64 | 17 | 3 | HP:0009237 | |
| HumanPheno | Fingernail dysplasia | 1.22e-03 | 16 | 17 | 2 | HP:0100798 | |
| HumanPheno | Palmar hyperhidrosis | 1.22e-03 | 16 | 17 | 2 | HP:0006089 | |
| HumanPheno | Paronychia | 1.22e-03 | 16 | 17 | 2 | HP:0001818 | |
| HumanPheno | Motor neuron atrophy | 1.24e-03 | 66 | 17 | 3 | HP:0007373 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 1.24e-03 | 66 | 17 | 3 | HP:0006262 | |
| HumanPheno | Prominent eyelashes | 1.38e-03 | 17 | 17 | 2 | HP:0011231 | |
| HumanPheno | Oral aversion | 1.38e-03 | 17 | 17 | 2 | HP:0012523 | |
| HumanPheno | Hypoplastic fifth toenail | 1.73e-03 | 19 | 17 | 2 | HP:0011937 | |
| HumanPheno | Dry hair | 1.92e-03 | 20 | 17 | 2 | HP:0011359 | |
| HumanPheno | Thickened skin | 1.95e-03 | 431 | 17 | 6 | HP:0001072 | |
| MousePheno | tongue muscle hypoplasia | 3.33e-06 | 2 | 26 | 2 | MP:0030421 | |
| MousePheno | skeletal muscle hypoplasia | 3.32e-05 | 5 | 26 | 2 | MP:0009460 | |
| MousePheno | abnormal tongue morphology | 6.25e-05 | 118 | 26 | 4 | MP:0000762 | |
| MousePheno | abnormal filiform papillae morphology | 6.95e-05 | 7 | 26 | 2 | MP:0000763 | |
| MousePheno | abnormal keratinocyte morphology | 1.33e-04 | 54 | 26 | 3 | MP:0002655 | |
| MousePheno | dilated cardiomyopathy | 1.82e-04 | 60 | 26 | 3 | MP:0002795 | |
| MousePheno | abnormal digestive system morphology | 2.46e-04 | 1233 | 26 | 9 | MP:0000462 | |
| MousePheno | abnormal intercostal muscle morphology | 3.44e-04 | 15 | 26 | 2 | MP:0002280 | |
| MousePheno | muscle hypoplasia | 3.44e-04 | 15 | 26 | 2 | MP:0000734 | |
| MousePheno | abnormal tongue muscle morphology | 3.93e-04 | 16 | 26 | 2 | MP:0004136 | |
| MousePheno | shortened PR interval | 8.22e-04 | 23 | 26 | 2 | MP:0010511 | |
| MousePheno | abnormal P wave | 8.95e-04 | 24 | 26 | 2 | MP:0004070 | |
| MousePheno | blistering | 8.95e-04 | 24 | 26 | 2 | MP:0001208 | |
| MousePheno | abnormal foot pad morphology | 1.05e-03 | 26 | 26 | 2 | MP:0000574 | |
| MousePheno | cardiomyopathy | 1.05e-03 | 109 | 26 | 3 | MP:0005330 | |
| MousePheno | digestive/alimentary phenotype | 1.05e-03 | 1500 | 26 | 9 | MP:0005381 | |
| MousePheno | abnormal tongue epithelium morphology | 1.13e-03 | 27 | 26 | 2 | MP:0000764 | |
| MousePheno | abnormal epidermal layer morphology | 1.48e-03 | 271 | 26 | 4 | MP:0001216 | |
| MousePheno | abnormal gastrulation | 1.53e-03 | 469 | 26 | 5 | MP:0001695 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.59e-03 | 1269 | 26 | 8 | MP:0011111 | |
| MousePheno | perinatal lethality, complete penetrance | 1.64e-03 | 712 | 26 | 6 | MP:0011089 | |
| MousePheno | decreased food intake | 2.03e-03 | 137 | 26 | 3 | MP:0011940 | |
| MousePheno | abnormal germ layer development | 2.34e-03 | 144 | 26 | 3 | MP:0001674 | |
| Domain | Intermediate_filament_CS | 6.10e-15 | 63 | 39 | 9 | IPR018039 | |
| Domain | Filament | 1.90e-14 | 71 | 39 | 9 | SM01391 | |
| Domain | IF | 2.16e-14 | 72 | 39 | 9 | PS00226 | |
| Domain | Filament | 2.47e-14 | 73 | 39 | 9 | PF00038 | |
| Domain | IF | 3.60e-14 | 76 | 39 | 9 | IPR001664 | |
| Domain | Keratin_2_head | 7.25e-12 | 24 | 39 | 6 | IPR032444 | |
| Domain | Keratin_2_head | 7.25e-12 | 24 | 39 | 6 | PF16208 | |
| Domain | Keratin_II | 1.24e-11 | 26 | 39 | 6 | IPR003054 | |
| Domain | Nucleotide-bd_a/b_plait | HNRNPA0 SRRT TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.35e-09 | 258 | 39 | 9 | IPR012677 |
| Domain | HnRNPA1 | 8.42e-09 | 3 | 39 | 3 | PF11627 | |
| Domain | HnRNPA1 | 8.42e-09 | 3 | 39 | 3 | IPR021662 | |
| Domain | RRM_1 | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 9.46e-09 | 208 | 39 | 8 | PF00076 |
| Domain | RRM | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.32e-08 | 217 | 39 | 8 | SM00360 |
| Domain | RRM_dom | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.87e-08 | 227 | 39 | 8 | IPR000504 |
| Domain | RRM | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.07e-08 | 230 | 39 | 8 | PS50102 |
| Domain | KRTAP | 2.18e-08 | 15 | 39 | 4 | PF11759 | |
| Domain | KRTAP_type6/8/16/19/20/21 | 2.18e-08 | 15 | 39 | 4 | IPR021743 | |
| Domain | Keratin_I | 3.11e-08 | 44 | 39 | 5 | IPR002957 | |
| Domain | - | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 3.28e-08 | 244 | 39 | 8 | 3.30.70.330 |
| Domain | BAF250/Osa | 4.25e-06 | 2 | 39 | 2 | IPR021906 | |
| Domain | BAF250_C | 4.25e-06 | 2 | 39 | 2 | IPR033388 | |
| Domain | BAF250_C | 4.25e-06 | 2 | 39 | 2 | PF12031 | |
| Domain | BRIGHT | 4.39e-04 | 15 | 39 | 2 | SM00501 | |
| Domain | - | 4.39e-04 | 15 | 39 | 2 | 1.10.150.60 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PF01388 | |
| Domain | ARID_dom | 4.39e-04 | 15 | 39 | 2 | IPR001606 | |
| Domain | ARID | 4.39e-04 | 15 | 39 | 2 | PS51011 | |
| Domain | Prefoldin | 9.90e-03 | 72 | 39 | 2 | IPR009053 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.02e-02 | 73 | 39 | 2 | IPR011545 | |
| Domain | DEAD | 1.02e-02 | 73 | 39 | 2 | PF00270 | |
| Pathway | REACTOME_KERATINIZATION | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 9.39e-20 | 217 | 38 | 16 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP19-4 KRTAP19-3 | 1.33e-18 | 153 | 38 | 14 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SOX17 KRT6A KRT6B KRT9 KRT10 ARID1B KRT24 OCLN KRTAP13-1 ARID1A KRT6C KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 HNRNPU | 6.36e-12 | 1432 | 38 | 21 | M509 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT6A KRT6B KRT9 KRT10 KRT24 KRTAP13-1 KRTAP6-1 KRT74 KRTAP19-5 KRT84 KRT77 KRTAP19-7 KRTAP19-4 KRTAP19-3 | 1.94e-11 | 502 | 38 | 14 | MM14537 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.42e-11 | 129 | 38 | 9 | M27649 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 6.37e-11 | 87 | 38 | 8 | MM15351 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.04e-08 | 201 | 38 | 8 | MM15411 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 5.89e-07 | 277 | 38 | 8 | MM15414 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.34e-06 | 212 | 38 | 7 | M14033 | |
| Pathway | WP_MRNA_PROCESSING | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.31e-06 | 451 | 38 | 9 | MM15946 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.03e-06 | 283 | 38 | 7 | M13087 | |
| Pathway | WP_MRNA_PROCESSING | 2.09e-05 | 126 | 38 | 5 | M39406 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.86e-04 | 612 | 38 | 8 | MM15547 | |
| Pathway | KEGG_SPLICEOSOME | 3.66e-04 | 127 | 38 | 4 | M2044 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.77e-04 | 724 | 38 | 8 | M16843 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 1.05e-03 | 18 | 38 | 2 | MM15334 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.74e-03 | 29 | 38 | 2 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 3.13e-03 | 31 | 38 | 2 | M39522 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.98e-03 | 35 | 38 | 2 | M47969 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 TAF15 ARID1A KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.31e-21 | 605 | 41 | 18 | 28977666 |
| Pubmed | HNRNPA0 DDX3Y KRT6A KRT6B KRT9 KRT10 TAF15 ARID1B HNRNPA1L2 KRT24 KRT6C HNRNPA1 HNRNPA2B1 KRT74 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.02e-20 | 1153 | 41 | 21 | 29845934 | |
| Pubmed | HNRNPA0 KRT6A KRT6B KRT9 KRT10 TAF15 FAM98B KRT6C HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.43e-20 | 346 | 41 | 15 | 25324306 | |
| Pubmed | 3.87e-17 | 63 | 41 | 9 | 16831889 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | HNRNPA0 HOXA10 KRT6A KRT6B KRT9 KRT10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.11e-17 | 430 | 41 | 14 | 38172120 |
| Pubmed | HNRNPA0 SRRT DDX3Y HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 6.04e-16 | 136 | 41 | 10 | 26979993 | |
| Pubmed | DDX3Y KRT6A KRT6B KRT9 KRT10 ARID1A KRT6C HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 9.02e-15 | 803 | 41 | 15 | 36517590 | |
| Pubmed | HNRNPA0 SRRT KRT6B KRT9 KRT10 TAF15 FAM98B KRT6C HNRNPA1 KRT74 HNRNPH3 HNRNPU DHX9 HNRNPA3 | 1.01e-14 | 641 | 41 | 14 | 36057605 | |
| Pubmed | 1.85e-14 | 37 | 41 | 7 | 17151017 | ||
| Pubmed | 2.87e-14 | 75 | 41 | 8 | 31527668 | ||
| Pubmed | KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 3.34e-14 | 40 | 41 | 7 | 12359730 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HNRNPA0 SRRT DDX3Y KRT6A KRT9 KRT10 TAF15 ARID1B ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.43e-14 | 1082 | 41 | 16 | 38697112 |
| Pubmed | HNRNPA0 HOXA10 KRT9 KRT10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.87e-14 | 421 | 41 | 12 | 34650049 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HNRNPA0 SRRT DDX3Y TAF15 ARID1B HNRNPA1L2 FAM98B ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.10e-13 | 954 | 41 | 15 | 36373674 |
| Pubmed | HNRNPA0 SRRT KRT6B KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPA3 | 1.16e-13 | 330 | 41 | 11 | 32529326 | |
| Pubmed | HNRNPA0 SRRT DDX3Y KRT6A KRT6B KRT10 TAF15 SRCIN1 HNRNPA1L2 FAM98B ARID1A HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.50e-13 | 1431 | 41 | 17 | 37142655 | |
| Pubmed | HNRNPA0 KRT6A KRT6B KRT10 TAF15 HNRNPA1L2 FAM98B ARID1A KRT6C HNRNPA1 HNRNPA2B1 KRT74 KRT84 KRT77 HNRNPU HNRNPR HNRNPA3 | 1.70e-13 | 1442 | 41 | 17 | 35575683 | |
| Pubmed | HNRNPA0 SRRT TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.22e-13 | 244 | 41 | 10 | 29884807 | |
| Pubmed | 2.37e-13 | 52 | 41 | 7 | 26265008 | ||
| Pubmed | 2.43e-13 | 24 | 41 | 6 | 30719818 | ||
| Pubmed | Isolation and characterization of mouse high-glycine/tyrosine proteins. | 4.44e-13 | 10 | 41 | 5 | 9374545 | |
| Pubmed | 4.67e-13 | 57 | 41 | 7 | 31862882 | ||
| Pubmed | 5.40e-13 | 107 | 41 | 8 | 32989256 | ||
| Pubmed | HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 6.28e-13 | 109 | 41 | 8 | 29511296 | |
| Pubmed | HNRNPA0 SRRT KRT6A KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPA3 | 1.08e-12 | 286 | 41 | 10 | 32041737 | |
| Pubmed | HNRNPA0 SRRT KRT9 KRT10 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.30e-12 | 725 | 41 | 13 | 27025967 | |
| Pubmed | 1.39e-12 | 12 | 41 | 5 | 11290294 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPA0 SRRT KRT6A TAF15 KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.67e-12 | 1024 | 41 | 14 | 24711643 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.67e-12 | 1257 | 41 | 15 | 36526897 |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 7.14e-12 | 147 | 41 | 8 | 28977470 | |
| Pubmed | DDX3Y KRT6A KRT6B KRT9 KRT10 KRT24 KRT6C HNRNPA2B1 KRT74 KRT84 KRT77 | 8.02e-12 | 488 | 41 | 11 | 31324722 | |
| Pubmed | HNRNPA0 SRRT KRT6B JUNB TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 8.20e-12 | 652 | 41 | 12 | 31180492 | |
| Pubmed | HNRNPA0 KRT6A KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU HNRNPR SRI HNRNPA3 | 8.57e-12 | 491 | 41 | 11 | 22623428 | |
| Pubmed | 1.06e-11 | 245 | 41 | 9 | 35652658 | ||
| Pubmed | 1.08e-11 | 17 | 41 | 5 | 15385554 | ||
| Pubmed | 1.09e-11 | 88 | 41 | 7 | 26318153 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.47e-11 | 254 | 41 | 9 | 28431233 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | HNRNPA0 SRRT MEX3A FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.68e-11 | 258 | 41 | 9 | 37794589 |
| Pubmed | 2.21e-11 | 266 | 41 | 9 | 19380743 | ||
| Pubmed | HNRNPA0 SRRT KRT6B KRT9 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.23e-11 | 711 | 41 | 12 | 33022573 | |
| Pubmed | Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb. | 2.49e-11 | 6 | 41 | 4 | 17611602 | |
| Pubmed | HNRNPA0 SRRT HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPA3 | 2.53e-11 | 172 | 41 | 8 | 26336360 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | HNRNPA0 SRRT KRT6A JUNB KRT9 KRT10 ARID1B HNRNPA1 HNRNPA2B1 HNRNPH3 DHX9 HNRNPR HNRNPA3 | 2.61e-11 | 922 | 41 | 13 | 27609421 |
| Pubmed | HNRNPA0 SRRT HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.88e-11 | 274 | 41 | 9 | 34244482 | |
| Pubmed | SRRT TAF15 FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.94e-11 | 551 | 41 | 11 | 34728620 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 FAM98B KRT6C HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.01e-11 | 1415 | 41 | 15 | 28515276 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT6A KRT6B KRT9 KRT10 FAM98B HNRNPA1 KRT84 KRT77 HNRNPU DHX9 HNRNPR | 3.36e-11 | 558 | 41 | 11 | 27591049 |
| Pubmed | 4.59e-11 | 22 | 41 | 5 | 12456657 | ||
| Pubmed | 4.93e-11 | 187 | 41 | 8 | 29777862 | ||
| Pubmed | 5.03e-11 | 109 | 41 | 7 | 12226669 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | HNRNPA0 KRT6A KRT6B KRT9 KRT10 KRT24 HNRNPA1 HNRNPA2B1 KRT77 HNRNPU DHX9 | 5.07e-11 | 580 | 41 | 11 | 35676659 |
| Pubmed | HNRNPA0 DDX3Y FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.34e-11 | 425 | 41 | 10 | 21081503 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HNRNPA0 SRRT KRT6B JUNB TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 6.20e-11 | 989 | 41 | 13 | 36424410 |
| Pubmed | 7.36e-11 | 115 | 41 | 7 | 17332742 | ||
| Pubmed | 7.47e-11 | 305 | 41 | 9 | 33194618 | ||
| Pubmed | HNRNPA0 HOXA10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 7.66e-11 | 441 | 41 | 10 | 31239290 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | HNRNPA0 KRT9 KRT10 OCLN HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 7.81e-11 | 604 | 41 | 11 | 37616343 |
| Pubmed | HNRNPA0 TAF15 ARID1B ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 9.45e-11 | 615 | 41 | 11 | 31048545 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | HNRNPA0 SRRT TAF15 MEX3A FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 9.57e-11 | 807 | 41 | 12 | 22681889 |
| Pubmed | 1.07e-10 | 206 | 41 | 8 | 22174317 | ||
| Pubmed | 1.56e-10 | 216 | 41 | 8 | 37640791 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HNRNPA0 DDX3Y KRT6B KRT9 KRT10 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.59e-10 | 1318 | 41 | 14 | 30463901 |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | HNRNPA0 FAM98B OCLN HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.75e-10 | 480 | 41 | 10 | 25437307 |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | KRT9 KRT10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.76e-10 | 336 | 41 | 9 | 31253590 |
| Pubmed | 1.85e-10 | 131 | 41 | 7 | 34551306 | ||
| Pubmed | HNRNPA0 HOXA10 KRT9 KRT10 TAF15 HNRNPA2B1 HNRNPU DHX9 HNRNPA3 | 1.95e-10 | 340 | 41 | 9 | 29478914 | |
| Pubmed | 2.01e-10 | 223 | 41 | 8 | 20020773 | ||
| Pubmed | 2.08e-10 | 69 | 41 | 6 | 18721477 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 2.47e-10 | 30 | 41 | 5 | 15782174 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 3.36e-10 | 238 | 41 | 8 | 35864588 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 3.48e-10 | 32 | 41 | 5 | 15848144 | |
| Pubmed | HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.71e-10 | 241 | 41 | 8 | 23125841 | |
| Pubmed | HNRNPA0 KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR SRI HNRNPA3 | 4.12e-10 | 707 | 41 | 11 | 19738201 | |
| Pubmed | HNRNPA0 DDX3Y HNRNPA1L2 HNRNPA1 HNRNPA2B1 DHX9 HNRNPR HNRNPA3 | 4.23e-10 | 245 | 41 | 8 | 21182205 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 4.36e-10 | 148 | 41 | 7 | 32538781 | |
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 5.45e-10 | 11 | 41 | 4 | 37142680 | |
| Pubmed | 6.49e-10 | 36 | 41 | 5 | 17289661 | ||
| Pubmed | HNRNPA0 DDX3Y HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR SRI | 6.53e-10 | 390 | 41 | 9 | 17643375 | |
| Pubmed | HNRNPA0 HNRNPA1L2 FAM98B HNRNPA1 HNRNPA2B1 KRT77 HNRNPU DHX9 SRI HNRNPA3 | 6.74e-10 | 552 | 41 | 10 | 36293380 | |
| Pubmed | HNRNPA0 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 6.76e-10 | 260 | 41 | 8 | 36199071 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | HNRNPA0 SRRT TAF15 ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.03e-09 | 411 | 41 | 9 | 35182466 |
| Pubmed | 1.06e-09 | 90 | 41 | 6 | 23151878 | ||
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 1.52e-09 | 3 | 41 | 3 | 23827524 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 29357356 | ||
| Pubmed | A widespread sequence-specific mRNA decay pathway mediated by hnRNPs A1 and A2/B1. | 1.52e-09 | 3 | 41 | 3 | 27151978 | |
| Pubmed | 1.52e-09 | 3 | 41 | 3 | 7543104 | ||
| Pubmed | 1.55e-09 | 289 | 41 | 8 | 37132043 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HNRNPA0 HOXA10 SRRT JUNB TAF15 ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.65e-09 | 1294 | 41 | 13 | 30804502 |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.78e-09 | 98 | 41 | 6 | 21942715 | |
| Pubmed | 2.09e-09 | 45 | 41 | 5 | 24654937 | ||
| Pubmed | 2.55e-09 | 104 | 41 | 6 | 36055981 | ||
| Pubmed | DDX3Y KRT6B TAF15 HNRNPA1L2 FAM98B HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPR HNRNPA3 | 2.62e-09 | 844 | 41 | 11 | 25963833 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 2.99e-09 | 16 | 41 | 4 | 15085952 | |
| Pubmed | 4.00e-09 | 112 | 41 | 6 | 28416769 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 4.19e-09 | 328 | 41 | 8 | 23398456 | |
| Pubmed | 4.45e-09 | 114 | 41 | 6 | 31553912 | ||
| Pubmed | 5.54e-09 | 340 | 41 | 8 | 24332808 | ||
| Pubmed | Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. | 6.08e-09 | 4 | 41 | 3 | 12426391 | |
| Pubmed | ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. | 6.08e-09 | 4 | 41 | 3 | 25616961 | |
| Pubmed | 6.36e-09 | 19 | 41 | 4 | 15234001 | ||
| Interaction | HEXIM1 interactions | HNRNPA0 DDX3Y KRT6A KRT6B KRT9 KRT10 TAF15 ARID1B HNRNPA1L2 KRT24 KRT6C HNRNPA1 HNRNPA2B1 KRT74 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.46e-18 | 913 | 41 | 21 | int:HEXIM1 |
| Interaction | CHD3 interactions | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 TAF15 MEX3A ARID1A KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 7.50e-17 | 757 | 41 | 19 | int:CHD3 |
| Interaction | CUL2 interactions | HNRNPA0 KRT6A KRT9 KRT10 TAF15 ARID1B KRT24 ARID1A KRT6C HNRNPA1 HNRNPA2B1 LOXL1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.52e-16 | 591 | 41 | 17 | int:CUL2 |
| Interaction | MYCN interactions | HNRNPA0 SRRT KRT6A JUNB KRT9 KRT10 TAF15 ARID1B HNRNPA1L2 MEX3A FAM98B ARID1A HNRNPA1 HNRNPA2B1 LOXL1 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR SRI HNRNPA3 | 1.28e-15 | 1373 | 41 | 22 | int:MYCN |
| Interaction | CHD4 interactions | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 TAF15 MEX3A ARID1A KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.79e-15 | 938 | 41 | 19 | int:CHD4 |
| Interaction | MIR106A interactions | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 6.87e-14 | 83 | 41 | 9 | int:MIR106A |
| Interaction | MIR18B interactions | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 8.58e-14 | 85 | 41 | 9 | int:MIR18B |
| Interaction | CUL5 interactions | HNRNPA0 KRT6A KRT6B KRT9 KRT10 TAF15 KRT24 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.47e-13 | 567 | 41 | 15 | int:CUL5 |
| Interaction | MIRLET7F1 interactions | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.19e-13 | 94 | 41 | 9 | int:MIRLET7F1 |
| Interaction | PRMT8 interactions | TAF15 FAM98B HNRNPA1 HNRNPH3 KRTAP6-3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.57e-13 | 104 | 41 | 9 | int:PRMT8 |
| Interaction | MIR34A interactions | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 5.57e-13 | 104 | 41 | 9 | int:MIR34A |
| Interaction | MIR138-1 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 9.60e-13 | 68 | 41 | 8 | int:MIR138-1 |
| Interaction | ACE2 interactions | HNRNPA0 SRRT KRT6B KRT9 KRT10 TAF15 HNRNPA1L2 FAM98B OCLN KRT6C HNRNPA1 HNRNPA2B1 KRT74 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.08e-12 | 1106 | 41 | 18 | int:ACE2 |
| Interaction | HNRNPA1 interactions | HNRNPA0 SRRT KRT6A KRT6B KRT9 KRT10 TAF15 HNRNPA1L2 FAM98B KRT6C HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.16e-12 | 945 | 41 | 17 | int:HNRNPA1 |
| Interaction | MIRLET7G interactions | HNRNPA0 DDX3Y TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.64e-12 | 117 | 41 | 9 | int:MIRLET7G |
| Interaction | MIR20A interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.94e-12 | 74 | 41 | 8 | int:MIR20A |
| Interaction | MIR7-3 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.42e-12 | 76 | 41 | 8 | int:MIR7-3 |
| Interaction | MIR16-1 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.42e-12 | 76 | 41 | 8 | int:MIR16-1 |
| Interaction | MIR199A2 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.42e-12 | 76 | 41 | 8 | int:MIR199A2 |
| Interaction | MIR98 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 3.00e-12 | 78 | 41 | 8 | int:MIR98 |
| Interaction | DDX39B interactions | SRRT KRT6A KRT6B KRT9 KRT10 MEX3A KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPU DHX9 HNRNPR | 3.12e-12 | 570 | 41 | 14 | int:DDX39B |
| Interaction | MIR222 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 3.34e-12 | 79 | 41 | 8 | int:MIR222 |
| Interaction | MIR143 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 3.70e-12 | 80 | 41 | 8 | int:MIR143 |
| Interaction | MEPCE interactions | HNRNPA0 DDX3Y KRT6A KRT6B KRT9 KRT10 TAF15 HNRNPA1L2 KRT6C HNRNPA1 HNRNPA2B1 KRT77 HNRNPU DHX9 HNRNPR HNRNPA3 | 3.92e-12 | 859 | 41 | 16 | int:MEPCE |
| Interaction | MIR10B interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 4.54e-12 | 82 | 41 | 8 | int:MIR10B |
| Interaction | CUL1 interactions | HNRNPA0 KRT6A KRT6B KRT9 KRT10 TAF15 KRT24 ARID1A KRT6C HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 5.27e-12 | 876 | 41 | 16 | int:CUL1 |
| Interaction | DCUN1D1 interactions | KRT9 KRT10 TAF15 KRT24 HNRNPA1 HNRNPA2B1 KRT77 HNRNPH3 HNRNPU DHX9 HNRNPA3 | 5.50e-12 | 275 | 41 | 11 | int:DCUN1D1 |
| Interaction | MIR31 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 5.53e-12 | 84 | 41 | 8 | int:MIR31 |
| Interaction | MIR7-2 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 5.53e-12 | 84 | 41 | 8 | int:MIR7-2 |
| Interaction | MIR200B interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 5.53e-12 | 84 | 41 | 8 | int:MIR200B |
| Interaction | MIR107 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 6.10e-12 | 85 | 41 | 8 | int:MIR107 |
| Interaction | MIR9-1 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 6.10e-12 | 85 | 41 | 8 | int:MIR9-1 |
| Interaction | KRT84 interactions | 6.78e-12 | 49 | 41 | 7 | int:KRT84 | |
| Interaction | MIR141 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 8.11e-12 | 88 | 41 | 8 | int:MIR141 |
| Interaction | RBM45 interactions | HNRNPA0 SRRT DDX3Y HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 8.93e-12 | 207 | 41 | 10 | int:RBM45 |
| Interaction | MIR200C interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.07e-11 | 91 | 41 | 8 | int:MIR200C |
| Interaction | NEDD8 interactions | HNRNPA0 KRT9 KRT10 TAF15 KRT24 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.21e-11 | 393 | 41 | 12 | int:NEDD8 |
| Interaction | MIR205 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.28e-11 | 93 | 41 | 8 | int:MIR205 |
| Interaction | COPS5 interactions | HNRNPA0 HOXA10 KRT6A KRT6B KRT9 KRT10 TAF15 KRT24 FAM98B KRT6C HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.35e-11 | 1102 | 41 | 17 | int:COPS5 |
| Interaction | MIR19B2 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.39e-11 | 94 | 41 | 8 | int:MIR19B2 |
| Interaction | MIRLET7A2 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.65e-11 | 96 | 41 | 8 | int:MIRLET7A2 |
| Interaction | MIRLET7F2 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.80e-11 | 97 | 41 | 8 | int:MIRLET7F2 |
| Interaction | MIR363 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.80e-11 | 97 | 41 | 8 | int:MIR363 |
| Interaction | MIR106B interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 1.96e-11 | 98 | 41 | 8 | int:MIR106B |
| Interaction | MIR128-2 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.13e-11 | 99 | 41 | 8 | int:MIR128-2 |
| Interaction | MIRLET7B interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.50e-11 | 101 | 41 | 8 | int:MIRLET7B |
| Interaction | MIRLET7D interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.50e-11 | 101 | 41 | 8 | int:MIRLET7D |
| Interaction | MIR25 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.50e-11 | 101 | 41 | 8 | int:MIR25 |
| Interaction | MIR15B interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.93e-11 | 103 | 41 | 8 | int:MIR15B |
| Interaction | MIR7-1 interactions | HNRNPA0 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 2.93e-11 | 103 | 41 | 8 | int:MIR7-1 |
| Interaction | MIRLET7E interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 3.71e-11 | 106 | 41 | 8 | int:MIRLET7E |
| Interaction | MIRLET7A1 interactions | HNRNPA0 TAF15 FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 4.31e-11 | 108 | 41 | 8 | int:MIRLET7A1 |
| Interaction | KRT17 interactions | KRT6A KRT6B KRT9 KRT10 KRT6C HNRNPA1 HNRNPA2B1 KRT84 KRT77 HNRNPU | 6.24e-11 | 252 | 41 | 10 | int:KRT17 |
| Interaction | TRIM31 interactions | HNRNPA0 HOXA10 KRT9 KRT10 TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 6.46e-11 | 454 | 41 | 12 | int:TRIM31 |
| Interaction | MIR9-3 interactions | 9.18e-11 | 70 | 41 | 7 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 1.02e-10 | 71 | 41 | 7 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.02e-10 | 71 | 41 | 7 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.02e-10 | 71 | 41 | 7 | int:MIR29B2 | |
| Interaction | MIR18A interactions | 1.24e-10 | 73 | 41 | 7 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 1.24e-10 | 73 | 41 | 7 | int:MIR29B1 | |
| Interaction | MIR15A interactions | 1.51e-10 | 75 | 41 | 7 | int:MIR15A | |
| Interaction | RNF208 interactions | 1.51e-10 | 75 | 41 | 7 | int:RNF208 | |
| Interaction | KRT5 interactions | 1.51e-10 | 193 | 41 | 9 | int:KRT5 | |
| Interaction | MIR429 interactions | 1.66e-10 | 76 | 41 | 7 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 1.82e-10 | 77 | 41 | 7 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 1.82e-10 | 77 | 41 | 7 | int:MIR200A | |
| Interaction | LARP7 interactions | HNRNPA0 DDX3Y KRT6A KRT6B KRT9 KRT10 TAF15 HNRNPA1L2 KRT6C HNRNPA1 HNRNPA2B1 KRT77 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.87e-10 | 1113 | 41 | 16 | int:LARP7 |
| Interaction | MIR92A1 interactions | 2.00e-10 | 78 | 41 | 7 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 2.00e-10 | 78 | 41 | 7 | int:MIR451A | |
| Interaction | MIR206 interactions | 2.19e-10 | 79 | 41 | 7 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 2.19e-10 | 79 | 41 | 7 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 2.19e-10 | 79 | 41 | 7 | int:MIR34C | |
| Interaction | MIR145 interactions | 2.62e-10 | 81 | 41 | 7 | int:MIR145 | |
| Interaction | MIR199A1 interactions | 3.40e-10 | 84 | 41 | 7 | int:MIR199A1 | |
| Interaction | MIR17 interactions | 3.69e-10 | 85 | 41 | 7 | int:MIR17 | |
| Interaction | MIR93 interactions | 3.69e-10 | 85 | 41 | 7 | int:MIR93 | |
| Interaction | MIR16-2 interactions | 3.69e-10 | 85 | 41 | 7 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 4.02e-10 | 86 | 41 | 7 | int:MIR20B | |
| Interaction | MIR29A interactions | 4.36e-10 | 87 | 41 | 7 | int:MIR29A | |
| Interaction | SMC5 interactions | HNRNPA0 SRRT DDX3Y TAF15 ARID1B HNRNPA1L2 FAM98B ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 4.62e-10 | 1000 | 41 | 15 | int:SMC5 |
| Interaction | MIR138-2 interactions | 4.73e-10 | 88 | 41 | 7 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 5.13e-10 | 89 | 41 | 7 | int:MIR29C | |
| Interaction | MIR221 interactions | 5.55e-10 | 90 | 41 | 7 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 5.55e-10 | 90 | 41 | 7 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 5.55e-10 | 90 | 41 | 7 | int:MIR1-1 | |
| Interaction | MIR155 interactions | 6.49e-10 | 92 | 41 | 7 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 6.49e-10 | 92 | 41 | 7 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 7.01e-10 | 93 | 41 | 7 | int:MIR214 | |
| Interaction | SNRPC interactions | HNRNPA0 SRRT TAF15 HNRNPA1 HNRNPA2B1 KRTAP19-5 KRTAP6-3 HNRNPU DHX9 HNRNPR HNRNPA3 | 8.31e-10 | 440 | 41 | 11 | int:SNRPC |
| Interaction | MIRLET7C interactions | 9.45e-10 | 97 | 41 | 7 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 9.45e-10 | 97 | 41 | 7 | int:MIR21 | |
| Interaction | KRT6A interactions | 1.01e-09 | 160 | 41 | 8 | int:KRT6A | |
| Interaction | NDN interactions | HNRNPA0 SRRT KRT6B KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPA3 | 1.13e-09 | 453 | 41 | 11 | int:NDN |
| Interaction | MIR19A interactions | 1.17e-09 | 100 | 41 | 7 | int:MIR19A | |
| Interaction | CAND1 interactions | HNRNPA0 KRT6B KRT9 KRT10 TAF15 ARID1B FAM98B HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.19e-09 | 894 | 41 | 14 | int:CAND1 |
| Interaction | MIRLET7A3 interactions | 1.35e-09 | 102 | 41 | 7 | int:MIRLET7A3 | |
| Interaction | FBP1 interactions | HNRNPA0 SRRT KRT6A KRT9 KRT10 HNRNPA1 HNRNPA2B1 HNRNPU DHX9 HNRNPA3 | 1.44e-09 | 348 | 41 | 10 | int:FBP1 |
| Interaction | PRR13 interactions | 1.46e-09 | 56 | 41 | 6 | int:PRR13 | |
| Interaction | MIR19B1 interactions | 1.55e-09 | 104 | 41 | 7 | int:MIR19B1 | |
| Interaction | MECP2 interactions | HNRNPA0 SRRT DDX3Y KRT6A KRT9 KRT10 TAF15 ARID1B ARID1A HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 HNRNPR HNRNPA3 | 1.57e-09 | 1287 | 41 | 16 | int:MECP2 |
| Cytoband | 21q22.1 | KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 3.97e-15 | 39 | 41 | 7 | 21q22.1 |
| Cytoband | 12q13.13 | 4.09e-09 | 67 | 41 | 5 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 4.21e-08 | 377 | 41 | 7 | chr21q22 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 9.21e-08 | 423 | 41 | 7 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p15 | 3.72e-03 | 101 | 41 | 2 | chr7p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 7.90e-03 | 149 | 41 | 2 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 8.67e-03 | 473 | 41 | 3 | chr17q21 | |
| GeneFamily | Keratins, type II | 9.63e-12 | 27 | 35 | 6 | 609 | |
| GeneFamily | Keratin associated proteins | KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 KRTAP6-3 KRTAP19-4 KRTAP19-3 | 1.39e-09 | 109 | 35 | 7 | 619 |
| GeneFamily | RNA binding motif containing | HNRNPA0 TAF15 HNRNPA1L2 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPR HNRNPA3 | 5.83e-09 | 213 | 35 | 8 | 725 |
| GeneFamily | Keratins, type I | 2.11e-05 | 28 | 35 | 3 | 608 | |
| GeneFamily | AT-rich interaction domain containing | 3.76e-04 | 15 | 35 | 2 | 418 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | KRT6A KRT6B KRT10 KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 IRX4 KRTAP19-4 KRTAP19-3 | 5.94e-13 | 204 | 41 | 10 | MM966 |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | DDX3Y KRT6A KRT6B KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 IRX4 KRTAP19-4 KRTAP19-3 | 3.43e-08 | 630 | 41 | 10 | MM1038 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | HOXA10 DDX3Y TAF15 HNRNPA1 HNRNPA2B1 HNRNPH3 HNRNPU DHX9 SRI HNRNPA3 | 6.02e-08 | 669 | 41 | 10 | M18635 |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.81e-07 | 173 | 41 | 6 | M650 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 4.04e-07 | 184 | 41 | 6 | M6593 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 4.23e-07 | 304 | 41 | 7 | M39208 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | DDX3Y JUNB KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 IRX4 KRTAP19-4 KRTAP19-3 | 6.49e-07 | 659 | 41 | 9 | MM1040 |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 6.59e-07 | 200 | 41 | 6 | M5777 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.87e-06 | 380 | 41 | 7 | M41703 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 4.90e-06 | 843 | 41 | 9 | M2356 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | JUNB KRTAP13-1 KRTAP6-1 KRTAP19-5 KRTAP19-7 IRX4 KRTAP19-4 KRTAP19-3 | 6.35e-06 | 650 | 41 | 8 | MM1042 |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP | 1.47e-05 | 200 | 41 | 5 | M5783 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.47e-05 | 200 | 41 | 5 | M5926 | |
| Coexpression | GU_PDEF_TARGETS_DN | 3.37e-05 | 40 | 41 | 3 | M10480 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 9.30e-05 | 56 | 41 | 3 | MM3852 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL | 1.23e-04 | 503 | 41 | 6 | M41690 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 1.59e-04 | 67 | 41 | 3 | M40299 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.84e-04 | 13 | 41 | 2 | MM743 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 1.85e-04 | 341 | 41 | 5 | M2879 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 2.14e-04 | 352 | 41 | 5 | MM3788 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 2.40e-04 | 569 | 41 | 6 | M12701 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 2.43e-04 | 195 | 41 | 4 | M13736 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 2.59e-04 | 79 | 41 | 3 | M40003 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 2.67e-04 | 200 | 41 | 4 | M5787 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 2.67e-04 | 200 | 41 | 4 | M5779 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 2.88e-04 | 204 | 41 | 4 | MM17090 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 2.89e-04 | 82 | 41 | 3 | M9224 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_DN | 2.92e-04 | 839 | 41 | 7 | M2099 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 3.64e-04 | 615 | 41 | 6 | M8673 | |
| Coexpression | BIDUS_METASTASIS_UP | 3.90e-04 | 221 | 41 | 4 | M15866 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC1 | 4.92e-04 | 21 | 41 | 2 | MM914 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC1 | 4.92e-04 | 21 | 41 | 2 | M2332 | |
| Coexpression | JIANG_MELANOMA_TRM3_CD8 | 5.02e-04 | 424 | 41 | 5 | M48967 | |
| Coexpression | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN | 5.41e-04 | 22 | 41 | 2 | M15807 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 6.44e-04 | 448 | 41 | 5 | MM1044 | |
| Coexpression | FISCHER_DREAM_TARGETS | 6.91e-04 | 969 | 41 | 7 | M149 | |
| Coexpression | JAEGER_METASTASIS_DN | 7.18e-04 | 260 | 41 | 4 | M10702 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 7.47e-04 | 705 | 41 | 6 | M1410 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.31e-09 | 146 | 41 | 6 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.75e-09 | 161 | 41 | 6 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-08 | 186 | 41 | 6 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-08 | 193 | 41 | 6 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-08 | 199 | 41 | 6 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-08 | 199 | 41 | 6 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.24e-07 | 129 | 41 | 5 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.61e-07 | 136 | 41 | 5 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.61e-07 | 136 | 41 | 5 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.46e-07 | 180 | 41 | 5 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 7.80e-07 | 187 | 41 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-07 | 190 | 41 | 5 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.84e-07 | 196 | 41 | 5 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 1.01e-06 | 197 | 41 | 5 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-06 | 197 | 41 | 5 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-06 | 197 | 41 | 5 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-06 | 197 | 41 | 5 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-06 | 198 | 41 | 5 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-06 | 198 | 41 | 5 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 199 | 41 | 5 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.09e-06 | 200 | 41 | 5 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.09e-06 | 200 | 41 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-06 | 200 | 41 | 5 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-06 | 200 | 41 | 5 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 112 | 41 | 4 | 32c6ab8e9b71c6c3df7e3e119b88e6ad1b895d50 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-06 | 122 | 41 | 4 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-06 | 122 | 41 | 4 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 125 | 41 | 4 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 130 | 41 | 4 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.51e-05 | 163 | 41 | 4 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.55e-05 | 164 | 41 | 4 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | facs-Marrow-T-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 168 | 41 | 4 | 0ece1e196d17c0f276424abd5cb43d528f40224b | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 170 | 41 | 4 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 180 | 41 | 4 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-05 | 183 | 41 | 4 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 187 | 41 | 4 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | 7ee9b00a8bd46f2da9218623bb2617b2e585f9d5 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 2.71e-05 | 189 | 41 | 4 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.76e-05 | 190 | 41 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.76e-05 | 190 | 41 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | H1299-infected-SARSCoV1|infected / Cell line, Condition and Strain | 2.76e-05 | 190 | 41 | 4 | f7bfeefc0f30f81710a5ddd979f19b0c910c4a42 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.76e-05 | 190 | 41 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 02f24202f9fdd46c648265a5b3b6f9066aa009fc | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte-new-cluster|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-05 | 194 | 41 | 4 | b847c5b4e8914b1c306bfff3d7119c32063784a8 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-05 | 194 | 41 | 4 | bd94d30584128628b34ed8c3857ce103586cfe2e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.18e-05 | 197 | 41 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 197 | 41 | 4 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 197 | 41 | 4 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.18e-05 | 197 | 41 | 4 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.18e-05 | 197 | 41 | 4 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 41 | 4 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.24e-05 | 198 | 41 | 4 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 198 | 41 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-05 | 198 | 41 | 4 | 3550798bfb9a426f3b28538a9778159bec2480d0 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-05 | 198 | 41 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 198 | 41 | 4 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.24e-05 | 198 | 41 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.24e-05 | 198 | 41 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-05 | 198 | 41 | 4 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.31e-05 | 199 | 41 | 4 | 99778178e3ec121802db938db8c5475d19b43fec | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 3.31e-05 | 199 | 41 | 4 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 199 | 41 | 4 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | 11.5|World / Age, Tissue, Lineage and Cell class | 3.31e-05 | 199 | 41 | 4 | e93807954c504745e295edc39883e1ed21f4cd93 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.31e-05 | 199 | 41 | 4 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.37e-05 | 200 | 41 | 4 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sepsis-Bac-SEP|Sepsis / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | 1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.65e-04 | 136 | 41 | 3 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.46e-04 | 149 | 41 | 3 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 149 | 41 | 3 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-04 | 153 | 41 | 3 | 14753baa9980f75206fefc3c8b43685fd4178a43 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.96e-04 | 156 | 41 | 3 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.96e-04 | 156 | 41 | 3 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | facs-Lung-24m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.42e-04 | 162 | 41 | 3 | 4e418bea07e35038b32a78a1e6632b6ec1208cdc | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.74e-04 | 166 | 41 | 3 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.74e-04 | 166 | 41 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.17e-04 | 171 | 41 | 3 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-04 | 171 | 41 | 3 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 5.26e-04 | 172 | 41 | 3 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | Striatum|World / BrainAtlas - Mouse McCarroll V32 | 5.26e-04 | 172 | 41 | 3 | 8da598d209b8a6646b9f4de1aed833f6fcbb9909 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.26e-04 | 172 | 41 | 3 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 5.26e-04 | 172 | 41 | 3 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| Computational | RNA splicing. | 2.69e-07 | 65 | 24 | 5 | MODULE_183 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.11e-06 | 50 | 24 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Neighborhood of DENR | 4.45e-06 | 51 | 24 | 4 | GNF2_DENR | |
| Computational | Neighborhood of DDX5 | 1.18e-05 | 65 | 24 | 4 | GCM_DDX5 | |
| Computational | Neighborhood of TDG | 6.11e-05 | 35 | 24 | 3 | GNF2_TDG | |
| Computational | Neighborhood of ACTG1 | 1.50e-04 | 124 | 24 | 4 | GCM_ACTG1 | |
| Computational | Genes in the cancer module 32. | 1.63e-04 | 241 | 24 | 5 | MODULE_32 | |
| Computational | Neighborhood of DFFA | 1.75e-04 | 129 | 24 | 4 | GCM_DFFA | |
| Computational | Genes in the cancer module 98. | 1.77e-04 | 393 | 24 | 6 | MODULE_98 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.79e-04 | 50 | 24 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Neighborhood of DEK | 2.78e-04 | 58 | 24 | 3 | GNF2_DEK | |
| Computational | Neighborhood of SMC1L1 | 3.39e-04 | 62 | 24 | 3 | MORF_SMC1L1 | |
| Computational | Intermediate filaments and MT. | 4.46e-04 | 68 | 24 | 3 | MODULE_438 | |
| Computational | Genes in the cancer module 198. | 4.71e-04 | 303 | 24 | 5 | MODULE_198 | |
| Computational | Neighborhood of HBP1 | 4.85e-04 | 70 | 24 | 3 | GCM_HBP1 | |
| Computational | Neighborhood of NPM1 | 5.27e-04 | 72 | 24 | 3 | GNF2_NPM1 | |
| Computational | Neighborhood of APEX1 | 1.08e-03 | 92 | 24 | 3 | GNF2_APEX1 | |
| Computational | Neighborhood of RRM1 | 1.45e-03 | 102 | 24 | 3 | MORF_RRM1 | |
| Computational | Genes in the cancer module 68. | 1.50e-03 | 26 | 24 | 2 | MODULE_68 | |
| Computational | Keratin. | 1.50e-03 | 26 | 24 | 2 | MODULE_298 | |
| Computational | Neighborhood of XRCC5 | 1.68e-03 | 235 | 24 | 4 | MORF_XRCC5 | |
| Computational | TFs and nuclear. | 1.73e-03 | 237 | 24 | 4 | MODULE_252 | |
| Computational | Genes in the cancer module 318. | 1.74e-03 | 28 | 24 | 2 | MODULE_318 | |
| Computational | Neighborhood of APEX1 | 2.00e-03 | 114 | 24 | 3 | GCM_APEX1 | |
| Computational | Genes in the cancer module 229. | 2.14e-03 | 31 | 24 | 2 | MODULE_229 | |
| Computational | Neighborhood of ZNF198 | 2.15e-03 | 117 | 24 | 3 | GCM_ZNF198 | |
| Computational | Neighborhood of DNMT1 | 2.21e-03 | 118 | 24 | 3 | MORF_DNMT1 | |
| Computational | Neighborhood of DAP3 | 2.26e-03 | 119 | 24 | 3 | GNF2_DAP3 | |
| Computational | Neighborhood of DEK | 2.57e-03 | 264 | 24 | 4 | MORF_DEK | |
| Computational | Genes in the cancer module 153. | 2.57e-03 | 34 | 24 | 2 | MODULE_153 | |
| Computational | Neighborhood of PPP2CA | 2.84e-03 | 129 | 24 | 3 | MORF_PPP2CA | |
| Computational | Neighborhood of RAD21 | 3.03e-03 | 37 | 24 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of ANP32B | 3.03e-03 | 37 | 24 | 2 | GNF2_ANP32B | |
| Computational | Neighborhood of FBL | 4.03e-03 | 146 | 24 | 3 | GNF2_FBL | |
| Computational | Neighborhood of CDC10 | 4.03e-03 | 146 | 24 | 3 | MORF_CDC10 | |
| Computational | Neighborhood of RAF1 | 4.08e-03 | 43 | 24 | 2 | GCM_RAF1 | |
| Computational | Neighborhood of RFC4 | 4.43e-03 | 151 | 24 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of UBE2N | 4.68e-03 | 154 | 24 | 3 | GCM_UBE2N | |
| Computational | Genes in the cancer module 83. | 5.11e-03 | 320 | 24 | 4 | MODULE_83 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.48e-03 | 50 | 24 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE | |
| Computational | Neighborhood of MYST2 | 6.36e-03 | 172 | 24 | 3 | GCM_MYST2 | |
| Computational | Neighborhood of HAT1 | 6.68e-03 | 175 | 24 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of MCM5 | 8.07e-03 | 61 | 24 | 2 | GNF2_MCM5 | |
| Computational | Neighborhood of RPA1 | 8.07e-03 | 61 | 24 | 2 | MORF_RPA1 | |
| Computational | Neighborhood of MSH2 | 8.07e-03 | 61 | 24 | 2 | MORF_MSH2 | |
| Computational | Neighborhood of PRKDC | 8.49e-03 | 191 | 24 | 3 | MORF_PRKDC | |
| Computational | Neighborhood of TERF1 | 9.67e-03 | 67 | 24 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of CBFB | 1.05e-02 | 70 | 24 | 2 | GCM_CBFB | |
| Computational | Neighborhood of RBBP6 | 1.05e-02 | 70 | 24 | 2 | GNF2_RBBP6 | |
| Computational | Neighborhood of AATF | 1.09e-02 | 209 | 24 | 3 | MORF_AATF | |
| Computational | Neighborhood of CUL1 | 1.11e-02 | 72 | 24 | 2 | MORF_CUL1 | |
| Computational | Neighborhood of CDK2 | 1.11e-02 | 72 | 24 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of KPNB1 | 1.14e-02 | 73 | 24 | 2 | GNF2_KPNB1 | |
| Computational | Genes in the cancer module 342. | 1.14e-02 | 213 | 24 | 3 | MODULE_342 | |
| Computational | Neighborhood of XRCC5 | 1.20e-02 | 75 | 24 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of UNG | 1.23e-02 | 76 | 24 | 2 | MORF_UNG | |
| Drug | teleocidin B | 6.92e-13 | 123 | 40 | 9 | CID000072425 | |
| Drug | AC1L9MJT | 9.78e-13 | 192 | 40 | 10 | CID000448959 | |
| Drug | sulfur mustard | 1.15e-12 | 130 | 40 | 9 | CID000010461 | |
| Drug | homocysteine thiolactone | 1.23e-12 | 131 | 40 | 9 | CID000107712 | |
| Drug | al-Badry | 9.98e-12 | 165 | 40 | 9 | CID000004545 | |
| Drug | bromovanin | 4.96e-11 | 127 | 40 | 8 | ctd:C515564 | |
| Drug | 1-2q | 1.46e-09 | 289 | 40 | 9 | CID000011820 | |
| Drug | Velcade (bortezomib | 1.38e-08 | 374 | 40 | 9 | CID000093860 | |
| Drug | clobestasol propionate | 1.91e-08 | 17 | 40 | 4 | CID000002791 | |
| Drug | dithranol | 2.45e-08 | 18 | 40 | 4 | CID000002202 | |
| Drug | Olux | 3.88e-08 | 20 | 40 | 4 | CID000032797 | |
| Drug | SC-791 | 1.00e-07 | 6 | 40 | 3 | CID010291510 | |
| Drug | betamethasone valerate | 1.62e-07 | 28 | 40 | 4 | CID000016533 | |
| Drug | AC1L1AUZ | 3.09e-07 | 157 | 40 | 6 | CID000001160 | |
| Drug | AC1NRA5C | 5.65e-07 | 174 | 40 | 6 | CID005287709 | |
| Drug | butyrate | 6.02e-07 | 767 | 40 | 10 | CID000000264 | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.07e-06 | 194 | 40 | 6 | 5620_DN | |
| Drug | adenosine 3',5'-cyclic phosphate | 2.73e-06 | 907 | 40 | 10 | CID000000274 | |
| Drug | cignolin | 2.81e-06 | 56 | 40 | 4 | CID000010187 | |
| Drug | N1-acetylspermidine | 5.61e-06 | 20 | 40 | 3 | CID000000496 | |
| Drug | Divonex | 6.50e-06 | 69 | 40 | 4 | CID000002522 | |
| Drug | ethylnylestradiol | HOXA10 KRT6A KRT6B JUNB KRT9 KRT10 KRT24 KRT6C KRT74 KRT84 KRT77 | 6.97e-06 | 1251 | 40 | 11 | CID000003285 |
| Drug | MK-6 | 9.91e-06 | 24 | 40 | 3 | CID005283547 | |
| Drug | Bhg-(2-1)fuc | 1.12e-05 | 25 | 40 | 3 | CID005287784 | |
| Drug | AC1L1B55 | 1.26e-05 | 454 | 40 | 7 | CID000001287 | |
| Drug | AC1L9LMC | 1.36e-05 | 83 | 40 | 4 | CID000448113 | |
| Drug | fulvestrant | 1.91e-05 | 484 | 40 | 7 | ctd:C070081 | |
| Drug | phorbol acetate myristate | KRT6A KRT6B JUNB KRT9 KRT10 KRT24 KRT6C KRT74 KRT84 KRT77 HNRNPH3 | 2.00e-05 | 1399 | 40 | 11 | CID000004792 |
| Drug | 2-Formyl-Protoporphryn Ix | 2.18e-05 | 31 | 40 | 3 | CID011963946 | |
| Drug | AGN 193109 | 2.18e-05 | 31 | 40 | 3 | CID000177238 | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.20e-05 | 194 | 40 | 5 | 2293_DN | |
| Drug | 4,4'-thiodiphenol | 2.41e-05 | 32 | 40 | 3 | CID000017570 | |
| Drug | chrysarobin | 3.74e-05 | 37 | 40 | 3 | CID000068111 | |
| Drug | tsuwabukinonol | 3.74e-05 | 37 | 40 | 3 | CID006440419 | |
| Drug | CaLam | 4.39e-05 | 39 | 40 | 3 | CID004126474 | |
| Drug | NSC134723 | 4.49e-05 | 6 | 40 | 2 | CID000281830 | |
| Drug | phenyl isocyanate | 4.49e-05 | 6 | 40 | 2 | ctd:C025319 | |
| Drug | PD153035 | 7.22e-05 | 127 | 40 | 4 | CID000004705 | |
| Drug | mant-GTP | 9.30e-05 | 50 | 40 | 3 | CID000128647 | |
| Drug | CD-III | 1.11e-04 | 53 | 40 | 3 | CID000066693 | |
| Drug | NSC34533 | 1.17e-04 | 54 | 40 | 3 | CID000003512 | |
| Drug | DIMIT | 1.31e-04 | 56 | 40 | 3 | CID000006624 | |
| Drug | benzalkonium | 1.31e-04 | 148 | 40 | 4 | CID000007681 | |
| Drug | SK&F 83959 | 1.48e-04 | 153 | 40 | 4 | ctd:C080703 | |
| Drug | Calcein AM | 1.77e-04 | 62 | 40 | 3 | CID000390986 | |
| Drug | sulfosuccinimidobiotin | 1.96e-04 | 12 | 40 | 2 | CID000083894 | |
| Drug | 1,4-pentanediamine | 3.11e-04 | 75 | 40 | 3 | CID000550880 | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 2797_DN | |
| Drug | 4-hydroxytestosterone | 3.49e-04 | 78 | 40 | 3 | CID000160615 | |
| Drug | AC1L1KPQ | 3.49e-04 | 78 | 40 | 3 | CID000005602 | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 3.67e-04 | 194 | 40 | 4 | 6066_DN | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 4358_DN | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 100uM; MCF7; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 334_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 1790_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; HL60; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 2196_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 6585_UP | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 6310_UP | |
| Drug | DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.97e-04 | 198 | 40 | 4 | 1121_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 3642_DN | |
| Drug | K-11 | 4.03e-04 | 17 | 40 | 2 | CID000469667 | |
| Drug | plakin | 4.04e-04 | 82 | 40 | 3 | CID000018752 | |
| Drug | Fipexide hydrochloride [34161-23-4]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.12e-04 | 200 | 40 | 4 | 3176_UP | |
| Drug | eye gene | 4.49e-04 | 369 | 40 | 5 | CID000004782 | |
| Drug | bromodeoxyuridine | 4.89e-04 | 376 | 40 | 5 | CID000006035 | |
| Disease | Pachyonychia Congenita | 1.66e-08 | 5 | 36 | 3 | C0265334 | |
| Disease | myopathy (implicated_via_orthology) | 3.49e-07 | 48 | 36 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Keratoderma, Palmoplantar | 9.24e-07 | 16 | 36 | 3 | C4551675 | |
| Disease | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | 4.34e-06 | 3 | 36 | 2 | cv:C1833662 | |
| Disease | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 4.34e-06 | 3 | 36 | 2 | C1833662 | |
| Disease | Pachyonychia congenita syndrome | 8.67e-06 | 4 | 36 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 8.67e-06 | 4 | 36 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 8.67e-06 | 4 | 36 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 8.67e-06 | 4 | 36 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.44e-05 | 5 | 36 | 2 | C3281201 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 2.16e-05 | 6 | 36 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.92e-05 | 145 | 36 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis | 4.91e-05 | 58 | 36 | 3 | C0002736 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 5.30e-05 | 169 | 36 | 4 | DOID:3908 (is_marker_for) | |
| Disease | neuroblastoma (is_implicated_in) | 6.47e-05 | 10 | 36 | 2 | DOID:769 (is_implicated_in) | |
| Disease | progression free survival, urinary bladder cancer | 9.48e-05 | 12 | 36 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | Coffin-Siris syndrome | 1.12e-04 | 13 | 36 | 2 | C0265338 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 5.36e-04 | 28 | 36 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Breast adenocarcinoma | 1.15e-03 | 41 | 36 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.15e-03 | 41 | 36 | 2 | C0496956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPGYSRPGAGGGGGG | 381 | Q8NFD5 | |
| FGGRSSGPYGGGGQY | 281 | Q32P51 | |
| YGGDRGGYGGDRGGY | 501 | Q92804 | |
| GVYGGPYGGSQGYGN | 71 | P78413 | |
| SVGYPYGGSGFGSYG | 101 | Q16625 | |
| RGYQGYPGGDYSGGP | 306 | O14497 | |
| GGYGSRAGGSYGFGG | 81 | P48668 | |
| GLGGFGGGSFRGSYG | 76 | P13645 | |
| LGYGCGGFGGLGYGY | 11 | Q3LI73 | |
| GFGAGSGIGYGFGGP | 106 | Q9NSB2 | |
| SGIGYGFGGPGFGYR | 111 | Q9NSB2 | |
| GFGGPGFGYRVGGVG | 116 | Q9NSB2 | |
| CGRGGGGSFGYSYGG | 61 | P35527 | |
| GGYGSRAGGSYGFGG | 81 | P02538 | |
| SYYGGLGYGCGGFGG | 6 | Q7Z4W3 | |
| LGYGCGGFGGLGYGY | 11 | Q7Z4W3 | |
| YGSGFGGYGYGSGFG | 46 | Q7Z4W3 | |
| SFRRLGYGGGYGGYG | 31 | Q3LI72 | |
| GFVYYRPAGGGVGAG | 201 | Q08397 | |
| GGYGSRAGGSYGFGG | 81 | P04259 | |
| GGGGGSGGIGYPYPR | 741 | Q00839 | |
| RGGGRGGYGYPPDYY | 451 | O43390 | |
| TGGFYSYGGGMGGGV | 116 | Q2M2I5 | |
| MRRGGDGYDGGYGGF | 136 | P31942 | |
| GYGTPDGLGGYGRGG | 311 | P31942 | |
| GGGGGGYYAHGGVYL | 51 | P31260 | |
| GFQGRGDYGGRGGYG | 386 | Q52LJ0 | |
| GRGGYGGRGYGDPYG | 401 | Q52LJ0 | |
| GTPGYGFCGYGGLGY | 11 | Q3LI64 | |
| GFCGYGGLGYGYGGL | 16 | Q3LI64 | |
| GYGGLGFGYGGLDCG | 36 | Q3LI67 | |
| GFGYGGLDCGYGGLG | 41 | Q3LI67 | |
| GYGGCGFPSLGYGVG | 131 | Q8IUC0 | |
| SYYGGLGYGCGGFGG | 6 | Q3SYF9 | |
| LGYGCGGFGGLGYGY | 11 | Q3SYF9 | |
| YGNSRGFGGGGYGGF | 626 | O15523 | |
| FRAGYGAGVGGGYRG | 1206 | Q08211 | |
| GFQRGGGRGAYGTGY | 1246 | Q08211 | |
| GGRGAYGTGYFGQGR | 1251 | Q08211 | |
| YYGAMGSPGAGGGRG | 296 | Q9H6I2 | |
| GGGYAPSCRYGGVGG | 406 | Q8IW70 | |
| YEMPYAGGGGGPTYG | 96 | Q9BXP5 | |
| FGGSPGYGGGRGGYG | 256 | P22626 | |
| GGGGPLYGDGYGFRL | 456 | Q9C0H9 | |
| NSGPYRGGYGGGGGY | 286 | Q13151 | |
| GDFGYGGYLFPGYGV | 361 | A1L020 | |
| RGGYGGGGGGSRGSY | 246 | P51991 | |
| NYGGGPGYSSRGGYG | 276 | P51991 | |
| PGYSSRGGYGGGGPG | 281 | P51991 | |
| FGGRSSGSPYGGGYG | 351 | P51991 | |
| GGPGYSGGSRGYGSG | 256 | P09651 | |
| HPGAGGGYYPGGYGG | 6 | P30626 | |
| GGYYPGGYGGAPGGP | 11 | P30626 | |
| PGQYFYPRGGGSGGG | 106 | P17275 | |
| GFGTSNFGLGGFGPY | 116 | Q7Z794 | |
| GGYGFRPGSGYGGGR | 71 | Q7RTS7 |